2024-10-09 05:09:12 pm | Source: StoxBox
Views On the TCS - Q3FY24 Earnings Preview by Sagar Shetty, Research Analyst, StoxBox

Below the Views On the TCS - Q3FY24 Earnings Preview by Sagar Shetty, Research Analyst, StoxBox
We expect TCS to report moderate revenue growth in Q2FY25, impacted by muted performance in India with incremental weakness in retail and CPG growth. The revenue growth would likely be based on the BSNL deal and the pickup of US BFSI services. We expect the marginal margin expansion after the wage hikes in Q1 and overall operational efficiency. We also expect margins to improve because of INR depreciation. Going ahead, management commentary on the FY25 demand environment, margin outlook, and near-term deal visibility will be crucial factors to watch out for.
Above views are of the author and not of the website kindly read disclaimer
Disclaimer:
The content of this article is for informational purposes only and should not be considered financial or investment advice. Investments in financial markets are subject to market risks, and past performance is not indicative of future results. Readers are strongly advised to consult a licensed financial expert or advisor for tailored advice before making any investment decisions. The data and information presented in this article may not be accurate, comprehensive, or up-to-date. Readers should not rely solely on the content of this article for any current or future financial references.
To Read Complete Disclaimer Click Here
Latest News

Evening Roundup : A Daily Report on Bullion Energy &...

Major 26 listed realty firms sell Rs 1.62 lakh cr pr...

Paytm Introduces Personalized UPI IDs to Enhance Pay...

HDFC Life Declares Rs. 4102 Cr. Bonus for Policyhold...

Perspective on AMFI Data by Anoop Vijaykumar, Head o...

Quote on Nifty 10 June 2025 by Rupak De, Senior Tech...

Quote on Market Wrap 10th June 2025 from Mr. Ajit Mi...

Quote on Evening Market 10 June 2025 by Mr. Vikram ...

Indian stock market ends flat as consolidation phase...

Kia begins mass production of next-gen military medi...